Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000904454-24-000526
Filing Date
2024-10-08
Accepted
2024-10-08 17:44:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 s13ga_100724-foghorn.htm SC 13G/A 36745
  Complete submission text file 0000904454-24-000526.txt   38272
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Subject) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91795 | Film No.: 241361060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address P.O. BOX 171627 BOSTON MA 02117
Business Address P.O. BOX 171627 BOSTON MA 02117 617-236-7909
Klarman Family Foundation (Filed by) CIK: 0001843177 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA
Type: SC 13G/A